New spinal implants under observation for back pain relief

NCT ID NCT06342765

Recruiting now Knowledge-focused Sponsor: SPINEVISION SAS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 330 adults who have received SpineVision spinal implants (Lumis, Plus, or Ulis) as part of their standard care for degenerative disc disease. Researchers will track pain, disability, and any side effects for up to 24 months after surgery to confirm the implants' safety and performance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SpineVision posterior fixation systems (Lumis, Plus, Ulis) implanted via pedicle fixation surgery
What this could lead to: If successful, this study could confirm that these spinal implants are safe and effective for treating degenerative disc disease, supporting their continued use.
What could go wrong: This is an observational study, not a controlled trial, so results may be less definitive. Risks include implant-related complications like infection or allergy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERVERTEBRAL DISC DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intervertebral disk degenerative disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTERVERTEBRAL DISC DEGENERATION

Contacts and locations

Locations

Clinique du dos Bordeaux-Terrefort
RECRUITING

Bruges, 33520, France
DOSCEA Pôle Rachis
RECRUITING

Bayonne, 64100, France
Orthéo Neurochirurgie
RECRUITING

Saint-Etienne, 42199, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.